Vision improvement
DeviceVision improvement for patients with refractive disorders (hyperopia and presbyopia)
NCT Number: NCT06597292
The VIS Opti-K Low Vision Aid device will be used to provide vision improvement to patients with refractive disorders (hyperopia and presbyopia).
Trial opening soon.
Get Notified40 year and older
All sexes
Interventional
Not applicable
Clarity Eye Institute, Toronto, Ontario, Canada
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Subjects who meet all of the following criteria are candidates for this study:
Exclusion criteria
Subjects who meet any of the following criteria are to be excluded from this study:
nclusion Criteria: -
Exclusion criteria
-
Vision improvement for patients with refractive disorders (hyperopia and presbyopia)
Time frame: Up to 24 months post-treatment
Uncorrected distance visual acuity (UDVA) is to be measured and reported using standard ETDRS visual acuity charts. UDVA change from baseline is also to be reported.
Time frame: Up to 24 months post-treatment
Uncorrected near visual acuity (UNVA) is to be measured and reported using standard near visual acuity charts. UNVA change from baseline is also to be reported.
Contact information is provided by the study sponsor or research team.
Harry Glen, MD
CONTACT
Michael Berry, PhD
CONTACT
VIS, Inc.
Industry
Vision Improvement for Patients With Presbyopia
Acronym: Opti-K Pres
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06869044
Eye Diseases, Hyperopia
Berkeley, California, United States
View Trial DetailsNCT07291739
Astigmatism, Eye Diseases
Makati City, Philippines
View Trial DetailsNCT07135570
AMD - Age-Related Macular Degeneration, Cardiovascular Diseases
Char Fasson, Bhola, Bangladesh
View Trial DetailsNCT04632784
Ametropia, Eye Diseases
Busan, South Korea
View Trial Details